| Literature DB >> 10953025 |
S Frank1, B Stallmeyer, H Kämpfer, N Kolb, J Pfeilschifter.
Abstract
Wound-healing disorders are a therapeutic problem of extensive clinical importance. Leptin-deficient ob/ob mice are characterized by a severely delayed wound healing that has been explained by the mild diabetic phenotype of these animals. Here we demonstrate that systemically and topically supplemented leptin improved re-epithelialization of wounds in ob/ob mice. Leptin completely reversed the atrophied morphology of the migrating epithelial tongue observed at the wound margins of leptin-deficient animals into a well-organized hyperproliferative epithelium. Moreover, topically supplemented leptin accelerated normal wound-healing conditions in wild-type mice. As assessed by immunohistochemistry, proliferating keratinocytes located at the wound margins specifically expressed the leptin-receptor subtype ObRb during repair. Additionally, leptin mediated a mitogenic stimulus to the human keratinocyte cell line HaCaT and human primary keratinocytes in vitro. Therefore, leptin might represent an effective novel therapeutic factor to improve impaired wound-healing conditions.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10953025 PMCID: PMC380250 DOI: 10.1172/JCI9148
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808